Chicago Capital Management, LLC

CIK 0001580162 · CHICAGO, IL · Quarter end: 2026-06-30 · Filed on: 2026-07-22 · Open the SEC source

Chicago Capital Management, LLC reported 27 positions worth $112.3M as of June 30, 2026 (13F filed July 22, 2026). Largest holding: NUVALENT INC (9.8%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$112.3M
2026 Q2
Positions
27
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
65.7%
Est. Net Flow (Q)
2026 Q2
10 / 27 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1670703107NUVALENT INCSH$11.1M9.84%115,500
203770N101APOGEE THERAPEUTICS INCSH$9.8M8.73%97,100
316115Q308CHART INDS INCSH$8.4M7.44%53,000
4BAND 0.5 04-01-28BANDWIDTH INCSH$7.6M6.79%8,153
5TMHC*TAYLOR MORRISON HOME CORPSH$7.2M6.39%133,000
6SABHLD 7.32 08-01-26SABRE GLBL INCSH$7.1M6.34%6,904
7RPD 0.25 03-15-27RAPID7 INCSH$6.3M5.62%6,520
8MGPI 1.875 11-15-41MGP INGREDIENTS INC NEWSH$5.9M5.28%6,068
9VERI 1.75 11-15-26VERITONE INCSH$5.4M4.80%5,500
10AMPH 2 03-15-29AMPHASTAR PHARMACEUTICALS INSH$5.0M4.43%5,440

The free plan shows the top 10 positions. The remaining 17 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Chicago Capital Management, LLC hold as of Q2 2026?

Chicago Capital Management, LLC reported 27 positions worth $112.3M in its Q2 2026 13F filing. Largest positions: NUVALENT INC (9.8%), APOGEE THERAPEUTICS INC (8.7%), CHART INDS INC (7.4%), BAND 0.5 04-01-28 (6.8%) and TMHC* (6.4%).

What did Chicago Capital Management, LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Chicago Capital Management, LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.